News & Perspective

Nov 23, 2018

Nov 23, 2018

ASP Scan (Weekly) for Nov 23, 2018

MDR Pseudomonas in Texas
Endoscope-linked MDRO outbreak
Pan-drug resistance in Ethiopia
Antibiotic use in NICUs
UK animal antibiotic use
Antimicrobial stewardship in Latin America, Caribbean
New antibiotic for travelers' diarrhea

Sep 29, 2017

Sep 29, 2017

ASP Scan (Weekly) for Sep 29, 2017

Money for HAI prevention
Drug resistance in supply chains
Restaurant antibiotic grades
Antibiotics for kids' diarrhea
MDR pathogens and gangrene
XDR Acinetobacter in Turkey

Jul 17, 2017

Jul 17, 2017

News Scan for Jul 17, 2017

Cyclospora in Texas
Non-prudent abx use in Europe
MERS super spreader
Smallpox vaccine deal

Mar 01, 2012

Mar 01, 2012

FDA clears first quadrivalent flu vaccine

(CIDRAP News) – The US Food and Drug Administration (FDA) yesterday approved the first quadrivalent influenza vaccine, an inhaled live attenuated influenza vaccine developed by MedImmune and modeled after its FluMist product.

The vaccine includes a second influenza B strain, which is designed to broaden protection against circulating strains. MedImmune plans to have the quadrivalent vaccine ready for the 2013-14 flu season.

Pages

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»